2’-FL: Study uncovers impact of DuPont HMO on gut microbiota and metabolite production

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

18 Mar 2020 --- Mineral ingredients producer Omya has unveiled a natural source of calcium for use in infant food applications. Omya Calcipur is made up of very fine particles and... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

13 Mar 2020 --- DuPont Nutrition & Biosciences is embarking on a four-year project with the APC Microbiome Ireland SFI Research Centre to rebalance the gut bacteria of babies... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

12 Mar 2020 --- One of Lallemand Health Solutions’ documented strains, Bifidobacterium lactis Lafti B94, has received a No Questions Letter (NQL) regarding the Generally... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

09 Mar 2020 --- The amount of infant rice cereals that do not surpass the US Food and Drug Administration (FDA)’s recommendation for inorganic arsenic levels has risen to 76... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

26 Feb 2020 --- A safety assessment of 3-Fucolsyllactose (3-FL) human milk oligosaccharide (HMO) brings DuPont Nutrition & Biosciences one step closer to the launch of CARE4U... Read More

trans